- Home
- Companies
- sierra leone
- testing services targeting to preclinical studies
Refine by
Testing Services Targeting To Preclinical Studies Suppliers Serving Sierra Leone
48 companies found
based inNewark, DELAWARE (USA)
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across ...
Interleukin 7 is also known as IL7, IL-7, and is a hematopoietic growth factor secreted by stromal cells in the red marrow and thymus. It is also produced by keratinocytes, dendritic cells, hepatocytes, neurons, and epithelial cells, but is not ...
based inStockholm, SWEDEN
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several ...
based inSan Diego, CALIFORNIA (USA)
Fivephoton Biochemicals specializes in the manufacturing and commercialization of convenient to use research tools for the biological, chemical and pharmaceutical research community. We offer innovative research solutions for the demands of a global ...
based inLa Tronche, FRANCE
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. ...
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology ...
based inThorold, ONTARIO (CANADA)
Norgen Biotek Corp. is dedicated to providing our customers with first class sample preparation kits for RNA, microRNA, DNA and protein purification, clean-up and concentration and to provide dedicated and expert support services to our customers ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Champions Oncology’s Analytical Testing platforms can be used to gather additional data at the endpoint of a preclinical model or ex vivo assay. Using multiplex cytokine assays with flow cytometry readouts, immune cell ...
based inRostock, GERMANY
INNOPROOF GmbH - Your independent, award-winning laboratory for accredited testing of implants and surgical instruments. We are accredited by ISO 17025:2018 standards and our test reports are accepted globally by MRA-ILAC recognition. From the ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the ...
based inMalvern, PENNSYLVANIA (USA)
TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to ...
OviTex, a Reinforced Tissue Matrix, was designed in collaboration with surgeons and healthcare providers to address the unmet clinical and financial needs in hernia repair and abdominal wall reconstruction. Our solutions are comprised of polymer ...
based inBerlin, GERMANY
iMouse GmbH, a Berlin-based company specializing in digital home cage monitoring solutions for preclinical research. Their flagship product, the iMouse system, aims to enhance objectivity, reduce human bias, and improve animal welfare in laboratory ...
iMouse GmbH offers a sophisticated AI-powered platform that is revolutionizing preclinical studies by providing digital biomarkers. This system processes video data of mice, converting their activities into comprehensive behavioral maps and charts. ...
based inGeumcheon-gu, SOUTH KOREA
We, ROKIT Healthcare, endeavor and strive to change the world with our customized artificial organ platforms. We want to provide the safest and effective organ regeneration platform services with our expertise in regenerative medicine. I believe ...
based inLowell, MASSACHUSETTS (USA)
Diagnosys is an inventor-owned private company devoted to the field of ophthalmic electrophysiology. Founded in 1983 as Doran Instruments, this company invented the Maculoscope, a focal ERG system that is the predicate device for most of the ...
based inHolytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide ...
based inWaltham, MASSACHUSETTS (USA)
Thermedical is developing a proprietary thermal ablation therapy that can treat significantly larger tissue volumes using a single device than conventional technology. Thermedical is a privately held medical device company based in Waltham, ...
based inCardiff, UNITED KINGDOM
Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical ...
Alesi Surgical and WIMAT are co-located and collaborate on research and development, testing, product design, pre-clinical evaluation and post-market clinical follow-up. This provides a unique level of access to experienced surgeons, surgical ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the pharmaceutical industry. However, ...
based inFoster City, CALIFORNIA (USA)
PointCross Life Sciences is a wholly-owned subsidiary of PointCross Inc. We are a global technology company providing the life sciences industry with solutions in big data analytics, management, visualization, and warehousing. Our offerings reduce ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
Mentanine®, supported by (cannabidiol “CBD” + IP formula) – molecules bond and synergistically attach to PPAR receptors allowing the formula to cross the blood-brain barrier (BBB) to target the central nervous ...
based inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a ...
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ ...